Abderrahim Oussalah

Prof Abderrahim Oussalah is an expert in Genetics at Centre Hospitalier Universitaire de Nancy (France). Abderrahim Oussalah has authored 133 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 604 (community average: 125). How the SLR is computed.

Genetics

Subspecialties: Hepatology - Gastroenterology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on October 28, 2026

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2008 - 2026

Source: PubMed

Centre Hospitalier Universitaire de Nancy

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 133

Citations

Citations: 3 609 1st author: 45 Last author: 15 Unique author: 1

Main journals

Aliment Pharmacol Ther 7

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title	Journal	Year	Citations
Cell-free DNA methylation for detection of early HCC: promising signals, but not yet a surveillance test. PMID 42933732 — liver diseases, cells, carcinoma, hepatocellular, cell-free nucleic acids, liver, dna methylation	J Hepatol Top journal	2026	0
A MUC13 Variant Enhances Intestinal Ferric Iron Absorption in Unexplained Hyperferritinemia. PMID 42929734 — cells, genes, mucins, integrins, transferrin, calreticulin, liver, iron overload, ferritins, genotype, exome, hyperferritinemia, absorption, plasma	Liver Int	2026	0
Exome Sequencing Reanalysis Improves Molecular Diagnosis in Genetic Cholestatic Liver Diseases. PMID 42925988 — liver diseases, genes, cholestasis, liver, diagnosis, exome	JHEP Rep	2026	0
Hyperhomocysteinemia and Vitamin B Deficiency as Potential Aggravating Factors in Huntington's Disease: A Prospective Monocentric Study. PMID 42386517 — vitamins, vitamin b deficiency, hyperhomocysteinemia, movement disorders, homocysteine, huntington disease	Mov Disord	2026	0
Circulating Methylated SEPT9 for Detection of Hepatocellular Carcinoma in Cirrhosis. PMID 42390849 — carcinoma, hepatocellular, neoplasms	JAMA Oncol	2026	3

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 3

By status:

Completed 2

Recruiting 1

By type:

Observational 2

Interventional 1

By Monocentric/Multicentric:

monocentric 3

multicentric2to4 0

multicentric5to9 0

multicentricup10 0

Main Topics

Digestive System Diseases 2

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study	Phase	Status	Start
mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis NCT06778317 — research design, genes, carcinoma, hepatocellular, promoter regions, genetic, blood, fibrosis, epigenomics, neoplasms, cohort studies, liver, biomarkers, liver neoplasms, precision medicine, plasma, carcinoma	N/A	Recruiting	2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS

Shopping Cart

System Maintenance Notice